[D2-4-1]Immunogenicity Profile of the Port Delivery System with Ranibizumab in Patients with nAMD
*Mauricio Maia 1, John Lowe 1, Steven Blotner 2, Galin Spicer 3, Natasha Singh 4, Shweta Vadhavkar 5, Derrick Kaufman 6, Ihsan Nijem 1, Weili Yan 1, Han Ting Ding 5, Matts Kaagedal 5, Giulio Barteselli 7, Keshwin Sharma 1, Katie Maass 5(1. Bioanalytical Sciences Department, Genentech/Roche , 2. Data & Statistical Sciences OMNI, Genentech/Roche , 3. Ophthalmology/US Medical Affairs, Genentech/Roche , 4. Clinical Safety Department, Genentech/Roche , 5. Clinical Pharmacology Department, Genentech/Roche , 6. Data & Statistical Science, Genentech/Roche , 7. Ophthalmology, Genentech/Roche )
閲覧にはパスワードが必要です
抄録パスワード認証
抄録の閲覧にはパスワードが必要です。パスワードを入力して認証してください。
抄録の閲覧にはパスワードが必要です。パスワードを入力して認証してください。
